Quantum Engine


DEDICATED TO NEXT GENERATION GENE MODIFIED CELL THERAPY

Striving toward the best solution to solid tumors and beyond!

A NEW PARADIGM FOR TREATING REFRACTORY SOLID TUMORS

GenomeFrontier Therapeutics, Inc. is committed to develop state-of-the-art products and platforms for production of next-generation gene-modified cell therapy which is highly effective, specific, persistent, and safe, thus achieving a sustained immune response capable of eradicating diseases.

We do this through our Quantum Engine™, which integrates four proprietary platforms: Quantum Nufect™, Quantum pBac™, iCellar™, and G-Tailor™, for improving vector delivery, therapeutic gene integration with lower size constraints, cell expansion capacity, and gene design effectiveness and efficiency, respectively.



A virus free genetic manipulation platform for efficient design and production of desired gene vectors


A proprietary buffer system for effective gene delivery into cells while maintaining high cell viability


An advanced, virus free and highly efficient piggyBac-based system with large payload capacity (~100 kb) for optimal therapeutic gene integration


Proprietary supplements and/or engineered cells for promoting robust cell expansion capability, while maintaining high cell quality